Cidara Therapeutics (CDTX) Earnings
|
Expand Research on CDTX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -4,451.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/6/25  |
Q325 | N/A | -$2.77 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | -$3.10 | $0.00 | -$3.10 | N/A | N/A | N/A |  | | Details | |
| 3/6/25 | Q424 | -$5.37 | $0.00 | -$5.37 | N/A | N/A | N/A | | | Details | |
| 8/13/24 | Q224 | -$20.65 | -$0.14 | -$20.51 | $300K | $6.95M | N/A | | | Details | |
| 5/15/24 | Q124 | -$2.28 | -$0.07 | -$2.21 | $8.46M | $13.05M | N/A | | | Details | |
| 3/25/24 | Q423 | N/A | -$0.10 | N/A | N/A | $11.53M | N/A | N/A | N/A | ||
| 3/18/24 | Q423 | N/A | -$0.10 | N/A | N/A | $11.53M | N/A | N/A | N/A | ||
| 3/11/24 | Q423 | N/A | -$0.10 | N/A | N/A | $11.53M | N/A | N/A | N/A |
